Huntsman Carole
Officer at MDGL
- Sold, on record
- $2.6M
- Dollars the filings state
- Form 4 sales
- 6
- Latest Mar 6, 2026
- Form 144 notices
- 7
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- MDGLMADRIGAL PHARMACEUTICALS, INC.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale MDGLRoutineMar 3, 2025 2025
Sold 1,834 shares at $325.98 ($598k)
Huntsman Carole, Chief Commercial Officer
10b5-1 planSold 17.6% of holdings ($3.4M position)8,604 shares leftFollows a Form 144Filing
- 2 Form 4 sale MDGLRoutineNov 21, 2025 +263 days
Sold 1,958 shares at $553.11 ($1.1M)
Huntsman Carole, Chief Commercial Officer
10b5-1 planSold 16.3% of holdings ($6.6M position)10,032 shares left2.8x usual sizeFollows a Form 144Filing
- 3 Form 144 notice MDGLNoticeNov 21, 2025 same day
Filed to sell 1,958 shares ($1.1M)
Huntsman Carole, Officer
10b5-1 plan2.8x usual sizeFiling
- 4 Form 4 sale MDGLRoutineJan 26, 2026 +66 days
Sold 910 shares at $493.78 ($449k)
Huntsman Carole, Chief Commercial Officer
10b5-1 planSold 9.1% of holdings ($5M position)9,122 shares left0.7x usual sizeFollows a Form 144Filing
- 5 Form 144 notice MDGLNoticeJan 26, 2026 same day
Filed to sell 570 shares ($274k)
Huntsman Carole, Officer
10b5-1 plan0.5x usual sizeFiling
- 6 Form 144 notice MDGLNoticeJan 26, 2026 same day
Filed to sell 340 shares ($163k)
Huntsman Carole, Officer
No 10b5-1 plan0.3x usual sizeFiling
- 7 Form 4 sale MDGLNo planMar 6, 2026 +39 days
Sold 419 shares at $431.94 ($181k)
Huntsman Carole, Chief Commercial Officer
No 10b5-1 planSold 3.2% of holdings ($5.7M position)12,692 shares left0.5x usual sizeFollows a Form 144Filing
- 8 Form 144 notice MDGLNoticeMar 6, 2026 same day
Filed to sell 419 shares ($184k)
Huntsman Carole, Officer
No 10b5-1 plan0.5x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (13)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | Mar 6, 2026 | MDGL | Officer | Form 144 notice | 419 | $184k | Notice | SEC | |
| Mar 6, 2026 | Mar 6, 2026 | MDGL | Chief Commercial Officer | Form 4 sale | 419 | $181k | 3.2% | No plan | SEC |
| Jan 26, 2026 | Jan 26, 2026 | MDGL | Officer | Form 144 notice | 340 | $163k | Notice | SEC | |
| Jan 26, 2026 | Jan 26, 2026 | MDGL | Officer | Form 144 notice | 570 | $274k | Notice | SEC | |
| Jan 26, 2026 | Jan 26, 2026 | MDGL | Chief Commercial Officer | Form 4 sale | 910 | $449k | 9.1% | Routine | SEC |
| Nov 21, 2025 | Nov 21, 2025 | MDGL | Officer | Form 144 notice | 1,958 | $1.1M | Notice | SEC | |
| Nov 21, 2025 | Nov 21, 2025 | MDGL | Chief Commercial Officer | Form 4 sale | 1,958 | $1.1M | 16.3% | Routine | SEC |
| Mar 3, 2025 | Mar 5, 2025 | MDGL | Chief Commercial Officer | Form 4 sale | 1,834 | $598k | 17.6% | Routine | SEC |
| Mar 3, 2025 | Mar 3, 2025 | MDGL | Officer | Form 144 notice | 1,834 | $626k | Notice | SEC | |
| Jan 24, 2025 | Jan 27, 2025 | MDGL | Chief Commercial Officer | Form 4 sale | 347 | $116k | 3.2% | No plan | SEC |
| Jan 24, 2025 | Jan 24, 2025 | MDGL | Officer | Form 144 notice | 347 | $118k | Notice | SEC | |
| Nov 21, 2024 | Nov 22, 2024 | MDGL | Chief Commercial Officer | Form 4 sale | 688 | $218k | 6.0% | No plan | SEC |
| Nov 21, 2024 | Nov 21, 2024 | MDGL | Officer | Form 144 notice | 688 | $218k | Notice | SEC |